TrialAIDS research and therapy2022

A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy.

Perez Nicholas Ochanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.